- Home
- MAPS vs TLSI Comparison
MAPS vs TLSI Comparison
Compare MAPS & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAPS
- TLSI
- Stock Information
- Founded
- MAPS 2008
- TLSI 2010
- Country
- MAPS United States
- TLSI United States
- Employees
- MAPS N/A
- TLSI N/A
- Industry
- MAPS Computer Software: Prepackaged Software
- TLSI Medical Specialities
- Sector
- MAPS Technology
- TLSI Health Care
- Exchange
- MAPS Nasdaq
- TLSI Nasdaq
- Market Cap
- MAPS 119.8M
- TLSI 124.9M
- IPO Year
- MAPS N/A
- TLSI N/A
- Fundamental
- Price
- MAPS $1.22
- TLSI $3.81
- Analyst Decision
- MAPS Buy
- TLSI Strong Buy
- Analyst Count
- MAPS 2
- TLSI 6
- Target Price
- MAPS $2.61
- TLSI $11.75
- AVG Volume (30 Days)
- MAPS 1.0M
- TLSI 52.7K
- Earning Date
- MAPS 11-12-2024
- TLSI 11-14-2024
- Dividend Yield
- MAPS N/A
- TLSI N/A
- EPS Growth
- MAPS N/A
- TLSI N/A
- EPS
- MAPS N/A
- TLSI N/A
- Revenue
- MAPS $183,311,000.00
- TLSI $26,891,000.00
- Revenue This Year
- MAPS N/A
- TLSI $60.97
- Revenue Next Year
- MAPS $9.09
- TLSI $53.69
- P/E Ratio
- MAPS N/A
- TLSI N/A
- Revenue Growth
- MAPS N/A
- TLSI 67.90
- 52 Week Low
- MAPS $0.70
- TLSI $3.50
- 52 Week High
- MAPS $1.49
- TLSI $10.42
- Technical
- Relative Strength Index (RSI)
- MAPS 52.06
- TLSI 43.11
- Support Level
- MAPS $1.07
- TLSI $3.50
- Resistance Level
- MAPS $1.49
- TLSI $4.17
- Average True Range (ATR)
- MAPS 0.13
- TLSI 0.36
- MACD
- MAPS -0.03
- TLSI -0.05
- Stochastic Oscillator
- MAPS 35.71
- TLSI 23.85
About MAPS WM Technology Inc.
WM Technology Inc is a technology and software infrastructure provider to the cannabis industry. It comprises B2C platform Weedmaps, and B2B software WM Business. Its revenues are derived primarily from monthly subscriptions to Weedmaps for Business, featured and deal listings and other WM Ad solutions. The Weedmaps for Business subscriptions generally have one-month terms that automatically renew unless notice of cancellation is provided in advance. Featured and deal listings and other WM Ad solutions are offered as add-on products to the Weedmaps for Business subscriptions. Featured and deal listings provide customers with premium placement ad solutions and discount and promotion pricing tools. Other WM Ad solutions include banner ads and promotion tiles on our marketplace ads.
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.